Davis FG, Smith TR, Gittleman H, Ostrom Q, Kruchko C, Barnholtz-Sloan J. Glioblastoma Incidence in Canada and the US in Comparison with England 1995-2015 [Letter to the Editor]. Neuro-Oncology (Accepted)

Walker EV, Ross J, Yuan Y, Smith TR, Davis FG. Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics. Curr Oncol. 2019;26(3):e292–e299. doi:10.3747/co.26.4273

Walker EV, Davis FG; CBTR founding affiliates. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013. Neuro Oncol. 2019;21(3):360–369. doi:10.1093/neuonc/noy195

Eckstrand A, Shack L, Pham T, Davis F. The Impact of Hospital Discharge Linkage on Case Ascertainment of Brain Tumours in the Alberta Cancer Registry, 2010-2015. Journal of Registry Management. 2018; 45;3, 109-116.

Yuan Y, Amjad S , Eckstrand A, Sevick R, Scott J, Devji S, Bertrand C, King M, Brunka V, Maplethorpe E, Walker E, Muanza T, Davis FG. On Capturing Radiological Diagnoses Of Brain Tumours To Provide Complete Population Data In Cancer Registries In Canada. Journal of Registry Management. 2018; 45: 167-172

Yuan Y, Ross J, Shi Q, Davis FG. Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000–2008. Current Oncology. 2017; 24(5):e341-e347. doi: 10.3747/co.24.3579.

Yuan Y , Shi Q , Li M , Nagamuthu C, Andres E , Davis FG. Canadian brain cancer survival rates by tumour type and region: 1992-2008. Canadian Journal of Public Health Revue Canadienne de Sante Publique. 2016; 107(1): e37 ́ -42.

Davis FG, Nagamuthu C*, Ross J* and Megyesi J. Current Status of Brain Tumour Surveillance in Canada and Why it Matters. Journal of Registry Management. 2015; 42(4):139-45.

Other Relevant Publications:

Zacharia D, Shaw A, Woods R, De P, Davis F. Case-Completeness of Nonmalignant Central Nervous System Tumours in the Canadian Cancer Registry, 2011-2015. Journal of Registry Management. 2018; 45:3; 117-131.